BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31266625)

  • 1. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.
    Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):521-534. PubMed ID: 31266625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.
    Sasadeusz J; Grigg A; Hughes PD; Lim SL; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):511-519. PubMed ID: 31266624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.
    López-Serrano P; Pérez-Calle JL; Sánchez-Tembleque MD
    World J Gastroenterol; 2013 Mar; 19(9):1342-8. PubMed ID: 23538480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.
    Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):487-492. PubMed ID: 31266622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.
    Sagnelli C; Pisaturo M; Calò F; Martini S; Sagnelli E; Coppola N
    World J Gastroenterol; 2019 Jul; 25(26):3299-3312. PubMed ID: 31341357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    Atteya A; Ahmad A; Daghstani D; Mushtaq K; Yassin MA
    Cancer Control; 2020; 27(1):1073274820976594. PubMed ID: 33297765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Hepatitis B reactivation in the setting of immunosuppression.
    Pattullo V
    Clin Mol Hepatol; 2016 Jun; 22(2):219-37. PubMed ID: 27291888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Nakamura J; Nagashima T; Nagatani K; Yoshio T; Iwamoto M; Minota S
    Int J Rheum Dis; 2016 May; 19(5):470-5. PubMed ID: 24698305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.
    Morisco F; Castiglione F; Rispo A; Stroffolini T; Vitale R; Sansone S; Granata R; Orlando A; Marmo R; Riegler G; Vecchi M; Biancone L; Caporaso N
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S40-8. PubMed ID: 21195371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.
    Sansone S; Guarino M; Castiglione F; Rispo A; Auriemma F; Loperto I; Rea M; Caporaso N; Morisco F
    World J Gastroenterol; 2014 Apr; 20(13):3516-24. PubMed ID: 24707134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overuse of prophylaxis in HBsAg and/or anti-HBc positive patients after increasing awareness to prevent reactivation in patients receiving immunosuppressive therapies: How rational are our prophylaxis decisions according to the literature?
    Yenilmez E; Cetinkaya RA
    Infez Med; 2019 Sep; 27(3):299-307. PubMed ID: 31545774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.
    Ergenç İ; Kani HT; Karabacak M; Cömert Özer E; Mehdiyev S; Jafarov F; Abacar KY; Kutluğ Ağaçkıran S; Sevik G; Aslan R; Alibaz Öner F; İnanç N; Atagündüz MP; Seçkin D; Özen Alahdab Y; Ergun T; Direskeneli H; Atuğ Ö
    Turk J Gastroenterol; 2023 Feb; 34(2):156-160. PubMed ID: 36445058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
    Fujita M; Sugiyama M; Sato Y; Nagashima K; Takahashi S; Mizokami M; Hata A
    J Viral Hepat; 2018 Nov; 25(11):1312-1320. PubMed ID: 29770539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.
    Watanabe K; Takase K; Ohno S; Ideguchi H; Nozaki A; Ishigatsubo Y
    Mod Rheumatol; 2012 Jun; 22(3):470-3. PubMed ID: 21901356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reactivation of chronic hepatitis B].
    Šperl J
    Vnitr Lek; 2013 Jul; 59(7):591-6. PubMed ID: 23909265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.